Request for Applications: Kidney SPORE
REQUEST FOR APPLICATIONS
Kidney Cancer Program of the Dana Farber/Harvard Cancer Center
Developmental Research Projects in Kidney Cancer
DUE DATE: 4/19/2013
The Kidney Cancer Program of the Dana Farber/Harvard Cancer Center, under the leadership of Dr. David McDermott, seeks applications for funding of research on kidney cancer. Funding will be provided through the Specialized Program of Research Excellence (SPORE) mechanism, a National Cancer Institute sponsored program. Applications must include one investigator on the faculty at Harvard Medical School at the level of Instructor or higher. While the proposed research can be basic or clinical, bench to bedside and bedside to bench strategies need to be addressed, since the purpose of this program is to promote translational research in kidney cancer. Applications will be judged on their scientific merit, relevance to kidney cancer, potential for future translation to clinical application, qualifications of the research team and the potential fit within the overall activities of the DF/HCC Kidney Cancer Program/Kidney Cancer SPORE. Funding will be for up to $61,500 in total costs (inclusive of F&A) per year. Although the opportunity exists for extending funding beyond one year, proposals should, in general, focus on a year’s worth of research. Applications should be sent electronically to Tara Johnston, Program Administrator at email@example.com no later than 4 p.m. on 04/19/13. A prior track record in kidney cancer research is preferred but not necessary. Minority and women applicants are strongly encouraged to apply.
Applications must contain the following components on PHS 398 Forms:
1. Cover letter with Title of proposal, PI, Institution and research administration contact.
2. Abstract of proposed research
3. Abbreviated Research Plan including the Specific Aims, Background and Significance, Preliminary Data, and Experimental Methods, not to exceed 5 pages exclusive of references.
4. Translational Goals of the project, potential application to kidney cancer and anticipated timeline (1 page)
5. NIH Biosketch
6. NIH Other Support Page
7. NIH Budget and Justification; must not exceed Total Costs of $61,500
8. Institutional Signature provided on a Letter of Intent to Collaborate for non BIDMC proposals.
9. IRB approval documents (if applicable)
10. Human Subject Training Certificate (if applicable)
Anticipated Award Dates: 06/01/13 – 05/31/14
We anticipate being able to fund 3-4 projects for that period.
- Kidney_SPORE_RFA.pdf11.3 K